Published in Mol Cell Ther on February 01, 2014
Platelets: still a therapeutical target for haemostatic disorders. Int J Mol Sci (2014) 0.75
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med (2013) 7.00
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med (2010) 5.59
Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med (2011) 4.81
Apixaban for extended treatment of venous thromboembolism. N Engl J Med (2012) 4.37
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med (2011) 3.30
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. Lancet (2010) 3.29